Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006144 · ClinicalTrials.gov registry record · Phase 2
A Study of HIV-Disease Development in Aging
A Phase 2 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 2
- Development phase
- 90
- Enrollment target
NCT00006144 is a Phase 2 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 90 participants.
The verdict
NCT00006144, a Phase 2 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the relationship between age and HIV disease progression. This study will explore the possible relationship between age and HIV disease progression. Older age is an important risk factor for faster disease development, but older people may respond better to combination drug therapy. This relationship needs to be understood better.
Interventions
- DRUG Stavudine
- DRUG Lopinavir/Ritonavir
- DRUG Emtricitabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2000-10 |
| Est. Completion | 2005-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006144
The ClinicalTrials.gov registry entry for NCT00006144 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Stavudine is the first listed.
NCT00006144 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006144 about?
NCT00006144 is a clinical study titled "A Study of HIV-Disease Development in Aging". The purpose of this study is to better understand the relationship between age and HIV disease progression. This study will explore the possible relationship between age and HIV disease progression. Older age is an important risk factor for faster disease development, but older people may respond b...
What is the current status of trial NCT00006144?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 90 participants. The study started on 2000-10. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00006144?
The interventions under investigation include: Stavudine (DRUG), Lopinavir/Ritonavir (DRUG), Emtricitabine (DRUG).
Who is sponsoring clinical trial NCT00006144?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.